Lise Tarnow: Clinical Trials

4 trials sponsored by Lise Tarnow, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 2 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2
Phase 31Completed 1

Follow Lise Tarnow: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes
Diabetic Neuropathy
CompletedLise Tarnow302012-09-012012-10-16
The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
nexium, Yoghurt, placebo+placebo - Type 2 Diabetes
Phase 3CompletedLise Tarnow412008-06-012012-09-03
Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With Diabetes
insulin detemir, saline - Diabetes Mellitus
Phase 4CompletedLise Tarnow402008-01-012012-09-03
Insulin Analogues and Severe Hypoglycaemia
insulin levemir / aspart, human insulin /insulin isophane - Type 1 Diabetes
Phase 4CompletedLise Tarnow1792007-05-012012-09-03

Conditions studied

Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Diabetic Neuropathies (1)  ·  Hypoglycemia (1)  ·  Insulin Resistance (1)

Interventions

Esomeprazole (1)  ·  Insulin Aspart (1)  ·  Insulin Detemir (1)  ·  Isophane Insulin, Human (1)  ·  Placebo Effect (1)  ·  Sodium Chloride (1)  ·  Yogurt (1)

Countries

Denmark (3)

Top investigators

Allan A. Vaag, MD, DMSc (1)

Results publications

PMID 22727048, PMID 23011351, PMID 24794703, PMID 27068361, PMID 27326862